MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on February 17, 2006; DOI: 10.1124/mol.105.019133


0026-895X/06/6905-1763-1771$20.00
Mol Pharmacol 69:1763-1771, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.105.019133v1
69/5/1763    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nguyen, C. H.
Right arrow Articles by Watts, V. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nguyen, C. H.
Right arrow Articles by Watts, V. J.

Dexamethasone-Induced Ras Protein 1 Negatively Regulates Protein Kinase C {delta}: Implications for Adenylyl Cyclase 2 Signaling

Chau H. Nguyen, and Val J. Watts

Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana

We identified dexamethasone-induced Ras protein 1 (Dexras1) as a negative regulator of protein kinase C (PKC) {delta}, and the consequences of this regulation have been examined for adenylyl cyclase (EC 4.6.1.1 [EC] ) type 2 (AC2) signaling. Dexras1 expression in human embryonic kidney 293 cells completely abolished dopamine D2 receptor-mediated potentiation of AC2 activity, which is consistent with previous reports of its ability to block receptor-mediated Gbeta{gamma} signaling pathways. In addition, Dexras1 significantly reduced phorbol 12-myristate 13-acetate (PMA)-stimulated AC2 activity but did not alter G{alpha}s-mediated cAMP accumulation. Dexras1 seemed to inhibit PMA stimulation of AC2 by interfering with PKC{delta} autophosphorylation. This effect was selective for the {delta} isoform because Dexras1 did not alter autophosphorylation of PKC{alpha} or PKC{epsilon}. Dexras1 disruption of PKC{delta} autophosphorylation resulted in a significant blockade of PKC kinase activity as measured by [{gamma}-32P]ATP incorporation using a PKC-specific substrate. Moreover, Dexras1 and PKC{delta} coimmunoprecipitated from whole-cell lysates. Dexras1 did not alter the membrane translocation of PKC{delta}; however, the ability of Dexras1 to interfere with PKC{delta} autophosphorylation was isoprenylation-dependent as determined using the farnesyltransferase inhibitor methyl {N-[2-phenyl-4-N [2(R)-amino-3-mecaptopropylamino] benzoyl]}-methionate (FTI-277) and a CAAX box-deficient Dexras1 (C277S) mutant. PMA-stimulated AC2 activity was also not affected by Dexras1 C277S. Taken as a whole, these data suggest that Dexras1 functionally interacts with PKC{delta} at the cellular membrane through an isoprenylation-dependent mechanism to negatively regulate PKC{delta} activity. Moreover our study suggests that Dexras1 acts to modulate the activation of AC2 in an indirect fashion by inhibiting both Gbeta{gamma}- and PKC-stimulated AC2 activity. The current study provides a novel role for Dexras1 in signal transduction.


Received for publication September 20, 2005.

Accepted for publication February 17, 2006.

Address correspondence to: Dr. Val J. Watts, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 Stadium Mall Drive, RHPH 210, West Lafayette, IN 47907. E-mail: wattsv{at}pharmacy.purdue.edu




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
A. Thapliyal, R. A. Bannister, C. Hanks, and B. A. Adams
The monomeric G proteins AGS1 and Rhes selectively influence G{alpha}i-dependent signaling to modulate N-type (CaV2.2) calcium channels
Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1417 - C1426.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
D. A. Dalmas, M. S. Scicchitano, Y. Chen, J. Kane, R. Mirabile, L. W. Schwartz, H. C. Thomas, and R. W. Boyce
Transcriptional Profiling of Laser Capture Microdissected Rat Arterial Elements: Fenoldopam-induced Vascular Toxicity as a Model System
Toxicol Pathol, April 1, 2008; 36(3): 496 - 519.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Newton and N. S. Holden
Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor?
Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
J. Lindsey
Dexamethasone-induced Ras-related protein 1 is a potential regulatory protein in B lymphocytes
Int. Immunol., May 1, 2007; 19(5): 583 - 590.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics